Literature DB >> 2450612

Adverse reactions during intravenous urography: are these due to histamine release?

C M Herd1, A R Robertson, D B Frewin, W B Taylor.   

Abstract

The effects of four different radiographic contrast media (Urovison 58%, Hexabrix 320, Iopamiro 370 and Omnipaque 300) have been examined with respect to histamine release, cardiovascular changes and adverse drug reaction (ADR) in a group of 200 patients undergoing intravenous urography. Each patient received only one of the four agents, which were allocated on a random basis. Urovison produced the greatest number of ADRs. Iopamiro caused the least. No significant correlation between the magnitude of the change in plasma histamine following injection of radiographic contrast medium and the production of a particular ADR could be demonstrated. Heart rate increased significantly following the administration of Urovison, Hexabrix and Iopamiro in the absence of any appreciable change in blood pressure. These results and our earlier findings would favour the use of the low-osmolality contrast media in intravenous urography to minimize ADRs, histamine release and patient discomfort.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2450612     DOI: 10.1259/0007-1285-61-721-5

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  4 in total

Review 1.  Reactions to radiocontrast material. Anaphylactoid events in radiology.

Authors:  P L Lieberman; R L Seigle
Journal:  Clin Rev Allergy Immunol       Date:  1999       Impact factor: 8.667

Review 2.  Anaphylactoid reactions to radiocontrast material.

Authors:  P Lieberman
Journal:  Clin Rev Allergy       Date:  1991 Fall-Winter

3.  Radiographic contrast media-induced histamine release: a comparative study with mast cells from different species.

Authors:  E U Amon; M Ennis; M Schnabel; C Schneider; W Lorenz
Journal:  Agents Actions       Date:  1989-04

4.  Histamine release from canine lung and liver mast cells induced by radiographic contrast media.

Authors:  M Ennis; E U Amon; W Lorenz
Journal:  Agents Actions       Date:  1989-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.